164 related articles for article (PubMed ID: 22214458)
1. Novel biotransformation process of podophyllotoxin to 4 β-sulfur-substituted podophyllum derivates with anti-tumor activity by Penicillium purpurogenum Y.J. Tang.
Bai JK; Zhao W; Li HM; Tang YJ
Curr Med Chem; 2012; 19(6):927-36. PubMed ID: 22214458
[TBL] [Abstract][Full Text] [Related]
2. Novel tandem biotransformation process for the biosynthesis of a novel compound, 4-(2,3,5,6-tetramethylpyrazine-1)-4'-demethylepipodophyllotoxin.
Tang YJ; Zhao W; Li HM
Appl Environ Microbiol; 2011 May; 77(9):3023-34. PubMed ID: 21398491
[TBL] [Abstract][Full Text] [Related]
3. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
4. Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity.
Zhao W; Bai JK; Li HM; Chen T; Tang YJ
Sci Rep; 2015 May; 5():10172. PubMed ID: 25959922
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways.
Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ
Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877
[TBL] [Abstract][Full Text] [Related]
6. Discover the leading compound of 4β-S-(5-fluorobenzoxazole)-4-deoxy-4'-demethylepipodophyllotoxin with millimolar-potency toxicity by modifying the molecule structure of 4'-demethylepipodophyllotoxin.
Zhang QY; Zhao W; Tang YJ
Eur J Med Chem; 2018 Oct; 158():951-964. PubMed ID: 30265994
[TBL] [Abstract][Full Text] [Related]
7. SAR analysis and biological studies of synthesized podophyllum derivates obtained by N linkage modification at C-4 position.
Wang H; Tang L; Tang Y; Yuan Z
Bioorg Med Chem; 2014 Nov; 22(21):6183-92. PubMed ID: 25282651
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of the C-4 esters of 4'-demethylepipodophyllotoxin.
Gupta RS; Chenchaiah PC
Anticancer Drug Des; 1987 Aug; 2(1):13-23. PubMed ID: 3449082
[TBL] [Abstract][Full Text] [Related]
9. [Research progress in biosynthesis of podophyllotoxin and its derivatives].
Meng Z; Yao T; Zhao W; Li H; Tang YJ
Sheng Wu Gong Cheng Xue Bao; 2021 Jun; 37(6):2026-2038. PubMed ID: 34227292
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
Chen SW; Tian X; Tu YQ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
[TBL] [Abstract][Full Text] [Related]
11. Comparison of carbon-sulfur and carbon-amine bond in therapeutic drug: 4β-S-aromatic heterocyclic podophyllum derivatives display antitumor activity.
Li JL; Zhao W; Zhou C; Zhang YX; Li HM; Tang YL; Liang XH; Chen T; Tang YJ
Sci Rep; 2015 Oct; 5():14814. PubMed ID: 26443888
[TBL] [Abstract][Full Text] [Related]
12. Triazole/thiadiazole substituted 4'-demethylepipodophyllotoxin derivatives induced apoptosis in HeLa cells by up-regulating TMEM133.
Zhao W; Duan Y; Li HM; Li S; Shen Y; Zhang Y; Li YZ; Tang YJ
Eur J Pharmacol; 2021 Aug; 905():174189. PubMed ID: 34033816
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new 4beta-5-Fu-substituted 4'-demethylepipodophyllotoxin derivatives.
Zhang FM; Yao XJ; Tian X; Tu YQ
Molecules; 2006 Nov; 11(11):849-57. PubMed ID: 18007391
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of heterogeneity product in 4'-demethylepipodophyllotoxin biotransformation process by using yeast extract as nitrogen source.
Zhao W; Li HM; Wan DJ; Tang YJ
Appl Microbiol Biotechnol; 2012 Jan; 93(1):107-15. PubMed ID: 21706170
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
[TBL] [Abstract][Full Text] [Related]
16. Increasing the distance between two monomers of topoisomerase IIβ under the action of antitumor agent 4β-sulfur-(benzimidazole) 4'-demethylepipodophyllotoxin.
Sun LY; Zhu LW; Tang YJ
Sci Rep; 2018 Oct; 8(1):14949. PubMed ID: 30297860
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
18. Tertiary amine mediated targeted therapy against metastatic lung cancer.
Zhou M; Li J; Li C; Guo L; Wang X; He Q; Fu Y; Zhang Z
J Control Release; 2016 Nov; 241():81-93. PubMed ID: 27639682
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds.
Hyder I; Yedlapudi D; Kalivendi SV; Khazir J; Ismail T; Nalla N; Miryala S; Sampath Kumar HM
Bioorg Med Chem Lett; 2015 Jul; 25(14):2860-3. PubMed ID: 26022842
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and potent cytotoxic activity of novel podophyllotoxin derivatives.
Li WQ; Wang XL; Qian K; Liu YQ; Wang CY; Yang L; Tian J; Morris-Natschke SL; Zhou XW; Lee KH
Bioorg Med Chem; 2013 Apr; 21(8):2363-2369. PubMed ID: 23490151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
